KMID : 0606920160240050523
|
|
Biomolecules & Therapeutics 2016 Volume.24 No. 5 p.523 ~ p.528
|
|
Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
|
|
Kim Young-Ae
Lee Dong-Gil Yi Kyu-Yang Lee Byung-Ho Jung Yi-Sook
|
|
Abstract
|
|
|
Urotensin II (UII) is a potent vasoactive peptide and mitogenic agent to induce proliferation of various cells including vascular smooth muscle cells (VSMCs). In this study, we examined the effects of a novel UII receptor (UT) antagonist, KR-36676, on vasoconstriction of aorta and proliferation of aortic SMCs. In rat aorta, UII-induced vasoconstriction was significantly inhibited by KR-36676 in a concentration-dependent manner. In primary human aortic SMCs (hAoSMCs), UII-induced cell proliferation was significantly inhibited by KR-36676 in a concentration-dependent manner. In addition, KR-36676 decreased UII-induced phosphorylation of ERK, and UII-induced cell proliferation was also significantly inhibited by a known ERK inhibitor U0126. In mouse carotid ligation model, intimal thickening of carotid artery was dramatically suppressed by oral treatment with KR-36676 (30 mg/ kg/day) for 4 weeks compared to vehicle-treated group. From these results, it is indicated that KR-36676 suppress UII-induced proliferation of VSMCs at least partially through inhibition of ERK activation, and that it also attenuates UII-induced vasoconstriction and vascular neointima formation. Our study suggest that KR-36676 may be an attractive candidate for the pharmacological management of vascular dysfunction.
|
|
KEYWORD
|
|
Urotensin II, Urotensin II receptor antagonist, KR-36676, ERK, Smooth muscle, Proliferation
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|